theragenomics: the world of alleles
Here, you find a list (table of alleles) found to play role in either drug effectiveness, drug safety, or targeted therapy.
| Gene | Allele | Guideline | URL |
|---|---|---|---|
| ABCG2 | rs2231142 reference (G) | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| ABCG2 | rs2231142 variant (T) | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CACNA1S | c.3257G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| CACNA1S | c.520C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| CACNA1S | Reference | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| CFTR | 2789+5G->A | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | 3272-26A->G | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | 3849+10kbC->T | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | 711+3A->G | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | A1067T | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | A455E | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | D110E | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | D110H | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | D1152H | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | D1270N | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | D579G | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | E193K | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | E56K | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | E831X | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | F1052V | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | F1074L | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | G1069R | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | G1244E | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | G1349D | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | G178R | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | G551D | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | G551S | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | ivacaftor non-responsive CFTR sequence | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | K1060T | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | L206W | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | P67L | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | R1070Q | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | R1070W | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | R117C | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | R117H | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | R347H | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | R352Q | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | R74W | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | S1251N | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | S1255P | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | S549N | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | S549R(A>C) | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | S549R(T>G) | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | S945L | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CFTR | S977F | CFTR and Ivacaftor | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ |
| CYP2B6 | *1 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *10 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *11 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *12 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *13 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *14 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *15 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *17 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *18 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *19 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *2 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *20 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *21 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *22 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *23 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *24 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *25 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *26 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *27 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *28 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *29 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *3 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *30 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *31 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *32 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *33 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *34 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *35 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *36 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *37 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *38 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *4 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *5 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *6 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *7 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *8 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2B6 | *9 | CYP2B6 and efavirenz | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ |
| CYP2C19 | *1 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *1 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *1 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *1 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *1 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *10 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *10 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *10 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *10 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *10 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *11 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *11 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *11 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *11 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *11 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *12 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *12 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *12 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *12 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *12 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *13 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *13 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *13 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *13 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *13 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *14 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *14 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *14 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *14 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *14 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *15 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *15 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *15 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *15 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *15 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *16 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *16 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *16 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *16 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *16 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *17 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *17 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *17 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *17 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *17 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *18 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *18 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *18 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *18 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *18 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *19 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *19 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *19 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *19 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *19 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *2 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *2 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *2 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *22 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *22 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *22 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *22 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *22 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *23 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *23 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *23 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *23 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *23 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *24 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *24 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *24 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *24 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *24 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *25 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *25 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *25 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *25 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *25 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *26 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *26 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *26 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *26 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *26 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *28 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *28 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *28 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *28 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *28 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *29 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *29 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *29 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *29 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *29 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *3 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *3 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *3 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *3 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *3 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *30 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *30 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *30 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *30 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *30 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *31 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *31 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *31 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *31 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *31 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *32 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *32 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *32 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *32 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *32 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *33 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *33 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *33 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *33 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *33 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *34 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *34 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *34 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *34 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *34 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *35 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *35 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *35 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *35 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *35 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *36 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *36 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *36 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *36 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *36 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *37 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *37 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *37 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *37 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *37 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *38 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *38 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *38 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *38 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *38 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *39 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *39 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *39 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *39 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *39 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *4 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *4 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *4 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *4 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *4 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *5 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *5 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *5 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *5 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *5 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *6 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *6 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *6 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *6 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *6 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *7 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *7 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *7 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *7 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *7 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *8 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *8 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *8 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *8 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *8 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *9 | CYP2C19 and Clopidogrel | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ |
| CYP2C19 | *9 | CYP2C19 and Proton Pump Inhibitors | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ |
| CYP2C19 | *9 | CYP2C19 and Voriconazole | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ |
| CYP2C19 | *9 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2C19 | *9 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2C9 | *1 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *1 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *1 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *1 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *10 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *10 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *10 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *10 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *11 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *11 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *11 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *11 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *12 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *12 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *12 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *12 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *13 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *13 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *13 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *13 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *14 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *14 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *14 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *14 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *15 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *15 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *15 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *15 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *16 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *16 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *16 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *16 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *17 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *17 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *17 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *17 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *18 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *18 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *18 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *18 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *19 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *19 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *19 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *19 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *2 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *2 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *2 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *2 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *20 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *20 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *20 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *20 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *21 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *21 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *21 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *21 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *22 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *22 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *22 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *22 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *23 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *23 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *23 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *23 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *24 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *24 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *24 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *24 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *25 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *25 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *25 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *25 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *26 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *26 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *26 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *26 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *27 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *27 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *27 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *27 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *28 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *28 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *28 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *28 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *29 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *29 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *29 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *29 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *3 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *3 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *3 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *3 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *30 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *30 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *30 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *30 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *31 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *31 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *31 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *31 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *32 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *32 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *32 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *32 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *33 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *33 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *33 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *33 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *34 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *34 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *34 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *34 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *35 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *35 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *35 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *35 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *36 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *36 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *36 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *36 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *37 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *37 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *37 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *37 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *38 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *38 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *38 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *38 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *39 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *39 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *39 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *39 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *4 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *4 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *4 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *4 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *40 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *40 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *40 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *40 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *41 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *41 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *41 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *41 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *42 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *42 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *42 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *42 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *43 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *43 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *43 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *43 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *44 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *44 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *44 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *44 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *45 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *45 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *45 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *45 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *46 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *46 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *46 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *46 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *47 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *47 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *47 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *47 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *48 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *48 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *48 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *48 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *49 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *49 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *49 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *49 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *5 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *5 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *5 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *5 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *50 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *50 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *50 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *50 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *51 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *51 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *51 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *51 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *52 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *52 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *52 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *52 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *53 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *53 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *53 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *53 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *54 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *54 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *54 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *54 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *55 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *55 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *55 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *55 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *56 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *56 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *56 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *56 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *57 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *57 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *57 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *57 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *58 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *58 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *58 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *58 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *59 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *59 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *59 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *59 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *6 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *6 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *6 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *6 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *60 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *60 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *60 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *60 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *61 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *61 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *61 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *61 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *62 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *62 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *62 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *62 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *63 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *63 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *63 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *63 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *64 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *64 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *64 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *64 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *65 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *65 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *65 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *65 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *66 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *66 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *66 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *66 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *67 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *67 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *67 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *67 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *68 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *68 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *68 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *68 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *69 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *69 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *69 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *69 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *7 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *7 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *7 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *7 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *70 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *70 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *70 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *70 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *71 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *71 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *71 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *71 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *72 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *72 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *72 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *72 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *73 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *73 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *73 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *73 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *74 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *74 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *74 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *74 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *75 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *75 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *75 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *75 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *8 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *8 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *8 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *8 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2C9 | *9 | CYP2C9 and NSAIDs | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ |
| CYP2C9 | *9 | CYP2C9, HLA-B and Phenytoin | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ |
| CYP2C9 | *9 | CYP2C9, VKORC1, CYP4F2 and Warfarin | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ |
| CYP2C9 | *9 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| CYP2D6 | *1 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *1 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *1 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *1 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *1 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *1 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *10 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *10 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *10 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *10 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *10 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *10 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *100 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *100 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *100 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *100 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *100 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *100 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *101 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *101 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *101 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *101 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *101 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *101 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *102 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *102 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *102 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *102 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *102 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *102 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *103 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *103 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *103 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *103 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *103 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *103 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *104 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *104 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *104 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *104 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *104 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *104 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *105 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *105 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *105 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *105 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *105 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *105 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *106 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *106 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *106 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *106 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *106 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *106 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *107 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *107 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *107 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *107 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *107 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *107 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *108 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *108 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *108 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *108 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *108 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *108 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *109 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *109 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *109 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *109 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *109 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *109 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *10x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *10x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *10x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *10x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *10x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *10x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *11 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *11 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *11 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *11 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *11 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *11 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *110 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *110 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *110 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *110 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *110 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *110 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *111 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *111 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *111 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *111 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *111 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *111 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *112 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *112 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *112 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *112 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *112 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *112 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *113 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *113 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *113 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *113 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *113 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *113 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *114 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *114 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *114 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *114 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *114 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *114 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *115 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *115 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *115 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *115 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *115 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *115 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *116 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *116 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *116 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *116 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *116 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *116 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *117 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *117 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *117 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *117 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *117 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *117 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *118 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *118 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *118 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *118 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *118 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *118 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *119 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *119 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *119 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *119 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *119 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *119 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *12 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *12 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *12 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *12 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *12 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *12 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *120 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *120 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *120 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *120 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *120 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *120 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *121 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *121 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *121 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *121 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *121 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *121 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *122 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *122 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *122 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *122 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *122 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *122 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *123 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *123 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *123 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *123 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *123 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *123 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *124 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *124 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *124 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *124 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *124 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *124 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *125 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *125 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *125 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *125 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *125 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *125 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *126 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *126 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *126 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *126 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *126 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *126 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *127 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *127 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *127 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *127 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *127 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *127 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *128 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *128 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *128 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *128 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *128 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *128 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *129 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *129 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *129 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *129 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *129 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *129 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *13 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *13 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *13 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *13 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *13 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *13 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *130 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *130 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *130 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *130 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *130 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *130 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *131 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *131 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *131 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *131 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *131 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *131 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *132 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *132 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *132 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *132 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *132 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *132 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *133 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *133 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *133 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *133 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *133 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *133 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *134 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *134 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *134 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *134 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *134 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *134 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *135 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *135 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *135 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *135 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *135 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *135 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *136 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *136 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *136 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *136 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *136 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *136 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *137 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *137 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *137 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *137 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *137 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *137 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *138 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *138 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *138 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *138 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *138 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *138 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *139 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *139 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *139 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *139 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *139 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *139 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *14 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *14 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *14 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *14 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *14 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *14 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *15 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *15 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *15 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *15 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *15 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *15 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *17 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *17 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *17 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *17 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *17 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *17 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *17x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *17x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *17x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *17x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *17x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *17x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *18 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *18 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *18 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *18 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *18 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *18 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *19 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *19 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *19 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *19 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *19 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *19 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *1x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *1x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *1x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *1x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *1x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *1x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *1x≥3 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *1x≥3 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *1x≥3 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *1x≥3 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *1x≥3 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *1x≥3 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *20 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *20 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *20 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *20 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *20 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *20 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *21 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *21 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *21 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *21 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *21 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *21 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *22 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *22 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *22 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *22 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *22 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *22 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *23 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *23 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *23 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *23 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *23 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *23 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *24 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *24 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *24 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *24 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *24 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *24 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *25 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *25 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *25 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *25 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *25 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *25 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *26 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *26 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *26 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *26 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *26 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *26 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *27 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *27 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *27 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *27 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *27 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *27 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *28 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *28 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *28 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *28 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *28 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *28 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *29 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *29 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *29 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *29 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *29 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *29 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *29x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *29x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *29x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *29x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *29x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *29x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *2x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *2x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *2x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *2x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *2x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *2x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *2x≥3 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *2x≥3 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *2x≥3 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *2x≥3 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *2x≥3 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *2x≥3 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *3 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *3 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *3 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *3 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *3 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *3 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *30 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *30 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *30 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *30 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *30 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *30 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *31 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *31 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *31 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *31 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *31 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *31 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *32 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *32 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *32 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *32 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *32 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *32 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *33 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *33 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *33 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *33 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *33 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *33 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *34 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *34 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *34 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *34 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *34 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *34 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *35 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *35 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *35 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *35 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *35 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *35 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *35x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *35x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *35x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *35x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *35x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *35x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *36 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *36 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *36 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *36 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *36 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *36 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *36x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *36x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *36x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *36x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *36x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *36x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *37 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *37 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *37 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *37 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *37 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *37 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *38 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *38 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *38 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *38 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *38 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *38 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *39 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *39 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *39 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *39 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *39 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *39 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *3x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *3x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *3x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *3x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *3x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *3x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *4 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *4 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *4 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *4 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *4 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *4 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *40 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *40 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *40 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *40 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *40 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *40 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *41 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *41 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *41 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *41 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *41 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *41 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *41x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *41x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *41x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *41x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *41x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *41x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *41x3 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *41x3 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *41x3 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *41x3 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *41x3 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *41x3 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *42 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *42 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *42 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *42 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *42 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *42 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *43 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *43 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *43 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *43 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *43 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *43 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *43x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *43x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *43x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *43x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *43x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *43x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *44 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *44 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *44 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *44 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *44 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *44 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *45 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *45 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *45 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *45 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *45 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *45 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *45x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *45x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *45x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *45x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *45x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *45x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *46 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *46 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *46 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *46 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *46 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *46 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *47 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *47 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *47 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *47 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *47 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *47 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *48 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *48 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *48 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *48 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *48 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *48 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *49 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *49 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *49 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *49 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *49 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *49 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *4x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *4x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *4x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *4x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *4x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *4x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *4x≥3 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *4x≥3 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *4x≥3 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *4x≥3 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *4x≥3 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *4x≥3 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *5 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *5 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *5 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *5 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *5 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *5 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *50 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *50 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *50 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *50 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *50 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *50 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *51 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *51 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *51 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *51 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *51 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *51 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *52 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *52 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *52 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *52 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *52 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *52 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *53 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *53 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *53 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *53 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *53 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *53 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *54 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *54 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *54 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *54 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *54 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *54 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *55 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *55 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *55 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *55 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *55 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *55 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *56 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *56 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *56 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *56 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *56 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *56 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *57 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *57 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *57 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *57 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *57 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *57 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *58 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *58 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *58 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *58 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *58 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *58 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *59 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *59 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *59 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *59 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *59 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *59 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *6 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *6 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *6 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *6 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *6 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *6 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *60 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *60 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *60 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *60 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *60 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *60 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *61 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *61 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *61 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *61 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *61 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *61 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *62 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *62 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *62 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *62 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *62 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *62 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *63 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *63 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *63 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *63 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *63 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *63 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *64 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *64 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *64 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *64 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *64 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *64 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *65 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *65 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *65 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *65 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *65 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *65 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *68 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *68 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *68 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *68 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *68 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *68 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *69 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *69 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *69 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *69 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *69 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *69 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *6x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *6x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *6x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *6x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *6x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *6x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *7 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *7 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *7 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *7 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *7 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *7 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *70 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *70 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *70 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *70 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *70 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *70 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *71 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *71 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *71 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *71 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *71 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *71 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *72 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *72 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *72 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *72 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *72 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *72 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *73 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *73 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *73 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *73 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *73 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *73 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *74 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *74 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *74 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *74 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *74 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *74 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *75 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *75 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *75 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *75 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *75 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *75 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *8 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *8 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *8 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *8 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *8 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *8 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *81 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *81 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *81 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *81 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *81 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *81 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *82 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *82 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *82 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *82 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *82 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *82 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *83 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *83 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *83 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *83 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *83 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *83 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *84 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *84 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *84 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *84 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *84 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *84 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *85 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *85 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *85 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *85 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *85 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *85 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *86 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *86 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *86 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *86 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *86 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *86 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *87 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *87 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *87 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *87 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *87 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *87 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *88 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *88 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *88 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *88 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *88 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *88 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *89 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *89 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *89 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *89 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *89 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *89 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *9 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *9 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *9 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *9 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *9 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *9 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *90 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *90 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *90 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *90 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *90 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *90 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *91 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *91 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *91 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *91 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *91 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *91 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *92 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *92 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *92 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *92 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *92 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *92 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *93 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *93 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *93 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *93 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *93 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *93 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *94 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *94 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *94 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *94 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *94 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *94 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *95 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *95 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *95 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *95 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *95 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *95 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *96 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *96 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *96 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *96 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *96 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *96 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *97 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *97 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *97 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *97 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *97 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *97 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *98 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *98 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *98 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *98 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *98 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *98 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *99 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *99 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *99 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *99 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *99 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *99 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP2D6 | *9x2 | CYP2D6 and Atomoxetine | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ |
| CYP2D6 | *9x2 | CYP2D6 and Ondansetron and Tropisetron | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ |
| CYP2D6 | *9x2 | CYP2D6 and Tamoxifen | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ |
| CYP2D6 | *9x2 | CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *9x2 | CYP2D6, CYP2C19 and Tricyclic Antidepressants | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ |
| CYP2D6 | *9x2 | CYP2D6, OPRM1, COMT, and Opioids | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ |
| CYP3A5 | *1 | CYP3A5 and Tacrolimus | https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/ |
| CYP3A5 | *3 | CYP3A5 and Tacrolimus | https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/ |
| CYP3A5 | *6 | CYP3A5 and Tacrolimus | https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/ |
| CYP3A5 | *7 | CYP3A5 and Tacrolimus | https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/ |
| CYP3A5 | *8 | CYP3A5 and Tacrolimus | https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/ |
| CYP3A5 | *9 | CYP3A5 and Tacrolimus | https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/ |
| DPYD | c.1003G>T (*11) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1024G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1057C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1108A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1129-5923C>G, c.1236G>A (HapB3) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1156G>T (*12) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1180C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1181G>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1218G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1260T>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1278G>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1294G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1314T>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1349C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1358C>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1371C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1403C>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1475C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1484A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1519G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1543G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1577C>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1601G>A (*4) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1615G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1627A>G (*5) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1679T>G (*13) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1682G>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1774C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1775G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1777G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1796T>C | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1896T>C | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1898delC (*3) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1905+1G>A (*2A) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1905C>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1906A>C | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.1990G>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2021G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2161G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2186C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2194G>A (*6) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2195T>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2279C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2303C>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2336C>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2482G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2582A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2623A>C | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2639G>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2656C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2657G>A (*9B) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2846A>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2872A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2915A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2921A>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2933A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.295_298delTCAT (*7) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2977C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2978T>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.2983G>T (*10) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.3049G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.3061G>C | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.3067C>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.313G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.343A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.451A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.46C>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.496A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.498G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.525G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.557A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.601A>C | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.61C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.62G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.632A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.703C>T (*8) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.775A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.85T>C (*9A) | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.868A>G | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.929T>C | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.934C>T | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | c.967G>A | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| DPYD | Reference | DPYD and Fluoropyrimidines | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ |
| G6PD | 202G>A_376A>G_1264C>G | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | A | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | A- 202A_376G | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | A- 680T_376G | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | A- 968C_376G | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Aachen | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Abeno | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Acrokorinthos | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Alhambra | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Amazonia | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Amiens | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Amsterdam | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Anadia | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Ananindeua | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Andalus | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Arakawa | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Asahi | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Asahikawa | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Aures | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Aveiro | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Bajo Maumere | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Bangkok | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Bangkok Noi | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Bao Loc | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Bari | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Belem | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Beverly Hills, Genova, Iwate, Niigata, Yamaguchi | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | B (reference) | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Brighton | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Buenos Aires | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Cairo | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Calvo Mackenna | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Campinas | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Canton, Taiwan-Hakka, Gifu-like, Agrigento-like | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Cassano | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Chatham | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Chikugo | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Chinese-1 | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Chinese-5 | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Cincinnati | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Cleveland Corum | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Clinic | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Coimbra Shunde | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Cosenza | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Costanzo | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Covao do Lobo | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Crispim | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Dagua | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Durham | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Farroupilha | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Figuera da Foz | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Flores | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Fukaya | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Fushan | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Gaohe | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Georgia | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Gidra | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Gond | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Guadalajara | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Guangzhou | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Haikou | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Hammersmith | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Harilaou | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Harima | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Hartford | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Hechi | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Hermoupolis | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Honiara | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Ierapetra | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Ilesha | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Insuli | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Iowa, Walter Reed, Springfield | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Iwatsuki | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Japan, Shinagawa | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Kaiping, Anant, Dhon, Sapporo-like, Wosera | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Kalyan-Kerala, Jamnaga, Rohini | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Kambos | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Kamiube, Keelung | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Kamogawa | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Kawasaki | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Kozukata | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Krakow | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Lages | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Lagosanto | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Laibin | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | La Jolla | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Lille | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Liuzhou | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Loma Linda | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Ludhiana | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Lynwood | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Madrid | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Mahidol | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Malaga | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Manhattan | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Mediterranean, Dallas, Panama‚ Sassari, Cagliari, Birmingham | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Mediterranean Haplotype | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Metaponto | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Mexico City | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Miaoli | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Minnesota, Marion, Gastonia, LeJeune | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Mira d'Aire | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Mizushima | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Montalbano | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Montpellier | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Mt Sinai | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Munich | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Murcia Oristano | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Musashino | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Namouru | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Nankang | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Nanning | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Naone | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Nara | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Nashville, Anaheim, Portici | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Neapolis | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Nice | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Nilgiri | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | No name | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | North Dallas | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Olomouc | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Omiya | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Orissa | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Osaka | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Palestrina | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Papua | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Partenope | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Pawnee | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Pedoplis-Ckaro | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Piotrkow | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Plymouth | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Praha | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Puerto Limon | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Quing Yan | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Radlowo | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Rehevot | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Rignano | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Riley | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Riverside | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Roubaix | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Salerno Pyrgos | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Santa Maria | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Santiago | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Santiago de Cuba, Morioka | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | S. Antioco | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Sao Borja | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Seattle, Lodi, Modena, Ferrara II, Athens-like | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Seoul | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Serres | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Shenzen | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Shinshu | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Sibari | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Sierra Leone | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Sinnai | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Songklanagarind | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Split | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Stonybrook | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Sugao | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Sumare | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Sunderland | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Surabaya | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Suwalki | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Swansea | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Taipei‚ Chinese-3 | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Telti/Kobe | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Tenri | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Tokyo, Fukushima | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Toledo | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Tomah | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Tondela | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Torun | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Tsukui | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Ube Konan | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Union,Maewo, Chinese-2, Kalo | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Urayasu | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Utrecht | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Valladolid | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Vancouver | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Vanua Lava | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Viangchan, Jammu | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Villeurbanne | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Volendam | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Wayne | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | West Virginia | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Wexham | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Wisconsin | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| G6PD | Yunan | G6PD | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ |
| MT-RNR1 | 1095T>C | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 1189T>C | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 1243T>C | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 1494C>T | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 1520T>C | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 1537C>T | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 1555A>G | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 1556C>T | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 663A>G | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 669T>C | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 747A>G | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 786G>A | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 807A>C | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 807A>G | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 827A>G | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 839A>G | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 896A>G | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 930A>G | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 951G>A | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 960C>del | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 961T>del | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 961T>del+Cn | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 961T>G | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | 988G>A | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| MT-RNR1 | Reference | MT-RNR1 and Aminoglycosides | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ |
| NUDT15 | *1 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| NUDT15 | *2 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| NUDT15 | *3 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| NUDT15 | *4 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| NUDT15 | *5 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| NUDT15 | *6 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| NUDT15 | *7 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| NUDT15 | *8 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| NUDT15 | *9 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| RYR1 | c.1021G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1021G>C | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.103T>C | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.11969G>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1201C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1209C>G | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.130C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.14387A>G | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.14477C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.14497C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.14512C>G | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.14545G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.14582G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.14693T>C | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1565A>C | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1589G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1597C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1598G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1654C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1840C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.1841G>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.487C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.488G>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.6487C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.6488G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.6502G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.6617C>G | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.6617C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7007G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7042_7044delGAG | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7048G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7063C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7124G>C | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7282G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7300G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7304G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7354C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7360C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7361G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7372C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7373G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.742G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.742G>C | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7522C>G | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7522C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.7523G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.9310G>A | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | c.982C>T | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| RYR1 | Reference | RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ |
| SLCO1B1 | *1 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *10 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *11 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *12 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *13 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *14 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *15 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *16 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *19 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *2 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *20 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *23 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *24 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *25 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *26 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *27 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *28 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *29 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *3 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *30 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *31 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *32 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *33 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *34 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *36 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *37 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *38 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *39 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *4 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *40 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *41 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *42 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *43 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *44 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *45 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *46 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *47 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *48 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *49 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *5 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *6 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *7 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *8 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| SLCO1B1 | *9 | SLCO1B1, ABCG2, CYP2C9, and Statins | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ |
| TPMT | *1 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *10 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *11 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *12 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *13 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *14 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *15 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *16 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *17 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *18 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *19 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *2 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *20 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *21 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *22 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *23 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *24 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *25 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *26 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *27 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *28 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *29 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *30 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *31 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *32 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *33 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *34 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *35 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *36 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *37 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *38 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *39 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *3A | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *3B | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *3C | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *4 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *40 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *41 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *5 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *6 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *7 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *8 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| TPMT | *9 | TPMT, NUDT15 and Thiopurines | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ |
| UGT1A1 | *1 | UGT1A1 and Atazanavir | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ |
| UGT1A1 | *27 | UGT1A1 and Atazanavir | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ |
| UGT1A1 | *28 | UGT1A1 and Atazanavir | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ |
| UGT1A1 | *36 | UGT1A1 and Atazanavir | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ |
| UGT1A1 | *37 | UGT1A1 and Atazanavir | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ |
| UGT1A1 | *6 | UGT1A1 and Atazanavir | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ |
| UGT1A1 | *80 | UGT1A1 and Atazanavir | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ |
| UGT1A1 | *80+*28 | UGT1A1 and Atazanavir | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ |
| UGT1A1 | *80+*37 | UGT1A1 and Atazanavir | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ |